#Bioretec #Finland #Tampere #Orthopedic Implants #Tuukka Paavola

Bioretec Welcomes Tuukka Paavola as New CFO

On January 15, 2026, Bioretec Ltd., famed for its innovative absorbable orthopedic implants, announced the appointment of Tuukka Paavola as the Chief Financial Officer (CFO), effective from January 20, 2025. This move is seen as a strategic step for the company as it continues to expand its global presence in the orthopedic sector.

A Leader in Finance

Tuukka Paavola is no stranger to the world of finance, bringing with him over two decades of expertise in capital markets, finance, and strategic planning. His previous roles include serving as CFO at Nightingale Health Plc and holding various leadership positions in Nordea Bank Plc. Notably, he is not just seasoned in finance but also holds a Master’s degree in Industrial Engineering and the Chartered Financial Analyst (CFA) designation, making him well-equipped to tackle the financial complexities of a fast-growing medical device company.

In his new role, Paavola will report directly to Bioretec’s CEO, Sarah van Hellenberg Hubar-Fisher, and will become a critical part of the management team. His responsibilities encompass overseeing all financial operations—ranging from planning and reporting to compliance management.

Bioretec's Commitment to Innovation

Bioretec is pioneering the future of orthopedic care with its commitment to developing fully biodegradable implant technologies. Their innovative RemeOs product line, for instance, utilizes a high-performance magnesium alloy, significantly enhancing surgical outcomes by facilitating fracture healing without the need for subsequent removal surgery. This aligns with Paavola's vision of driving long-term sustainable financial growth for the company.

Paavola expressed his enthusiasm about his new position, stating, "I am delighted for the opportunity to join Bioretec at this very exciting moment and help the company in continuing its global growth journey." His words reflect the optimism surrounding his new role and the bright future ahead for Bioretec.

A Smooth Transition

During the transition phase, Anne-Mari Matikainen has been serving as the Interim CFO. The senior management team at Bioretec acknowledged her crucial role in navigating through challenging times while supporting the company's strategic objectives. Matikainen will continue to assist in the transition until February 13, ensuring that the organization remains stable during this pivotal time.

CEO Sarah van Hellenberg Hubar-Fisher welcomes Paavola, emphasizing that his leadership will be vital as Bioretec gears up to solidify its status as a global leader in absorbable implants focused on healing:

"We are excited to welcome Tuukka to Bioretec, and we look forward to his leadership and contributions as we continue to advance our mission."

Looking Ahead

With his extensive background in finance and strategic oversight, Tuukka Paavola is poised to play a crucial role in shaping the financial future of Bioretec. The company has set its sights on further innovations that can transform orthopedic treatments and significantly improve patient outcomes. Bioretec’s ongoing commitment to developing cutting-edge solutions is intertwined with its goal of thriving in about 40 countries around the globe.

Paavola's arrival marks a new chapter for Bioretec as it aims to revolutionize orthopedic care by focusing on effective and patient-friendly solutions. The company’s history underscores its dedication to health and innovation, laying a promising foundation for the future under Paavola’s financial leadership.

To learn more about Bioretec and their innovative products, visit Bioretec's Website.